Medevice Capital
Medevice is a venture capital firm based in Paris, France, founded in 2011. The firm specializes in investing in medical technology and e-health innovation projects, focusing on healthcare, digital health, and wellness sectors within the region. With a team composed of experienced entrepreneurs who have worked in healthcare companies, Medevice possesses a deep understanding of the potential of various projects. This expertise enables the firm to provide meaningful support to emerging companies as they navigate challenges in the industry.
Top Stages
2 past transactions
Dyameo
Seed Round in 2021
Dyameo specializes in developing single-use endoscopic probes aimed at the instant detection of cancer cells. The company's medical devices are designed to aid in the diagnosis of cancer by discriminating cancer cells at an early stage during endoscopic examinations. This technology enables medical professionals to detect cancer cells more efficiently, enhancing the diagnostic process and potentially improving patient outcomes.
Imactis
Series A in 2017
Imactis is a company focused on computer-assisted interventional radiology, dedicated to enhancing the efficiency and safety of minimally invasive needle procedures such as biopsies, tumor ablations, vertebroplasties, infiltrations, and drainages. The company develops and markets innovative solutions that assist interventional radiologists by improving accuracy, facilitating complex procedures, and reducing both the duration of interventions and the need for multiple controls. Its technology simplifies multi-needle alignment, provides real-time treatment planning, and enables medical professionals to navigate around critical structures without angular limitations. Through these advancements, Imactis aims to improve patient outcomes and overall care in medical institutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.